Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
crispr
deals
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
life sciences
medicare
merck
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
administration
What
talk
3
×
bio
roundup
active
advice
analyze
approval
asked
becker
billions
biogen’s
biopharmaceutical
building
cannabis
companies
convo
dollars
drug
earlier
eaton
european
failures
founders
gene
healthcare
impact
investors
life
littered
looking
market
medicinal
michael
millions
moves
nash
new
news
opportunities
outlook
Language
unset
Current search:
talk
×
biotech
×
@techcrunch.com
2 years ago
8 cannabis investors share their outlook on the European market in H1 2022
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More